You have 9 free searches left this month | for more free features.

Unknown Primary Squamous Cell Carcinoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the

Recruiting
  • Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +2 more
  • Atezolizumab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jan 19, 2022

Head Neck Cancer, Unknown Primary Cancer, Head and Neck Squamous Cell Carcinoma Trial in Dallas (Pegsitacianine)

Not yet recruiting
  • Head and Neck Cancer
  • +2 more
  • Pegsitacianine
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Oct 8, 2022

Head and Neck Squamous Cell Carcinoma Trial in Toronto (da Vinci Surgical System Model IS4000)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • da Vinci Surgical System Model IS4000
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 16, 2021

Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior

Recruiting
  • Solid Tumor
  • +15 more
  • RAPA-201 Rapamycin Resistant T Cells
  • Chemotherapy Prior to RAPA-201 Therapy
  • Hackensack, New Jersey
    Hackensack University Medical Center
Dec 23, 2021

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma in Cervical Lymph Node Trial in Houston

Active, not recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +5 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 17, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Laryngeal

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +5 more
  • External Beam Radiation Therapy
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 1, 2022

Head Neck Cancer Trial (IMRT)

Completed
  • Head and Neck Cancer
  • IMRT
  • (no location specified)
Sep 3, 2020

Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell

Active, not recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +19 more
  • Duarte, California
  • +18 more
Aug 24, 2022

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +24 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 6, 2022

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Aug 13, 2021

PET-CT for Squamous Cell Carcinoma of Neck Nodes Unknown Primary

Completed
  • Squamous Cell Cancer
  • PET-CT
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Oct 17, 2019

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Los Angeles, California
  • +35 more
Aug 20, 2022

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo

Recruiting
  • Cancer, All Types
  • +44 more
    • Gainesville, Georgia
      Specicare
    Dec 2, 2020

    Subjects With p16 Positive/HPV Positive Squamous Cell Carcinomas of the Oropharynx Trial in Philadelphia (Obtaining Human

    Completed
    • Subjects With p16 Positive/HPV Positive Squamous Cell Carcinomas of the Oropharynx
    • Obtaining Human tissue
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Apr 9, 2020

    Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning

    Unknown status
    • Squamous Cell Carcinoma of the Oropharynx
    • Step serial sectioning histological processing
    • Birmingham, United Kingdom
      University Hospitals Birmingham NHS Foundation Trust
    Nov 5, 2019

    Squamous Cell Carcinoma of Head and Neck Trial in France (bintrafusp alfa)

    Terminated
    • Squamous Cell Carcinoma of Head and Neck
    • bintrafusp alfa
    • Bordeaux, France
    • +7 more
    Mar 28, 2022

    Esophageal Squamous Cell Carcinoma in Malawi

    Active, not recruiting
    • Esophageal Squamous Cell Carcinoma
      • Lilongwe, Malawi
      • +1 more
      Aug 11, 2022

      Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Neck Cancer Metastatic Trial in Baltimore (Nivolumab 480mg and

      Active, not recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +2 more
      • Nivolumab 480mg and surgical resection
      • Baltimore, Maryland
        Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
      Feb 25, 2022

      Carcinoma of Unknown Primary Trial in Calgary, Edmonton, Ottawa (Pembrolizumab Injection)

      Recruiting
      • Carcinoma of Unknown Primary
      • Pembrolizumab Injection
      • Calgary, Alberta, Canada
      • +2 more
      Feb 18, 2022

      Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck Trial in Tucson, Tampa

      Terminated
      • Cutaneous Squamous Cell Carcinoma
      • Cutaneous Squamous Cell Carcinoma of the Head and Neck
      • Tucson, Arizona
      • +1 more
      Jul 26, 2022

      Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck

      Active, not recruiting
      • Metastatic Head and Neck Squamous Cell Carcinoma
      • +2 more
      • Cetuximab
      • +2 more
      • Washington, District of Columbia
      • +1 more
      Mar 25, 2022

      Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

      Active, not recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +14 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2022